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ABSTRACT
With rapid advances in gut microbiome research, fecal bile acids are increasingly being
monitored as potential biomarkers of diet related disease susceptibility. As such, rapid, robust
and reliable methods for their analysis are of increasing importance. Herein is described a
simple extraction method for the analysis of bile acids in feces suitable for subsequent
quantification by liquid chromatography and tandem mass spectrometry. A C18 column
separated the analytes with excel-lent peak shape and retention time repeatability maintained
across 800 injections. The intra-day and inter-day precision and accuracy was greater than 80
%. Recoveries ranged from 83.58 to 122.41%. The limit of detection and limit of quantification
were in the range 2.5 to 15 nM, respectively. The optimised method involved extracting bile
acids from wet feces with minimal clean up. A second aliquot of fecal material was dried and
weighed to correct for water content. Extracting from dried feces showed reduced recovery that
could be corrected for by spiking the feces with deuterated standards prior to drying. Storage
of the extracts and standards in a refrigerated autosampler prior to analysis on the LC-MS is
necessary. Multiple freeze-thaws of both standards and standards lead to poor recoveries for
some bile acids. The method was successfully applied to 100 human fecal samples.
Keywords: Bile acids; Fecal; LC-MS/MS; Extraction; Stability
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1. Introduction
Bile acids (BA) are water-soluble, amphipathic primary end products of cholesterol
metabolism that play an essential role in cholesterol homeostasis as well as the digestion and
absorption of dietary lipids [1,2]. Furthermore, they are involved in multiple physiological
processes such as the regulation of lipid, glucose and energy metabolism, prevention of
bacterial overgrowth, facilitation of intestinal calcium absorption and have recently been
described as important signaling molecules central to maintenance of human health [3,4].
During their passage through the intestinal tract BA undergo a series of transformations and
the majority (95%) are reabsorbed and recycled by the enterohepatic circulation. The ~5% that
reach the colon are modified due to their interactions with the gut microbiota and are excreted
in the feces. The complex interplay between BA and the gut microbiota has gained increasing
attention as it is now understood to have significant influence on the pathophysiology of many
diseases [3]. Fecal BA profiles have been purported to be biomarkers of disease susceptibility,
therefore, robust and accurate analysis of BA in feces is important. However, the multiple
isometric variations of BA structure and their chemical properties have presented challenges
in their separation and detection [3].
A range of techniques have been reported for the analysis of BA including HPLC with UV
detection, gas chromatography coupled with flame ionisation (GC-FID) and more recently gas
chromatography mass spectrometry (GC-MS) and liquid chromatography mass spectrometry
(LC-MS) [3,5–8]. The latter is the technique of choice as it allows for separation of
configurational isomers; the BA form stable negatively charged ions that can be sensitively
detected by MS and, unlike for GC, requires no derivatisation step [3,5,6].
For LC-MS analysis, fecal samples are typically spiked with one or more isotopically labelled
bile acid standard as part of the extraction process. Separation is generally achieved using a
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C18 column and gradient elution using a buffered acetonitrile water mobile phase. MS
detection is possible for conjugated BA, as glycine and taurine moieties give stable [M – H]fragments [3,6]. Selected Ion Recording (SIR) is necessary for unconjugated BA as no stable
product ions are usually found and therefore the same parent and product ions are employed
[3,6].
An earlier, comprehensive study by Setchell et al (1987) highlighted the lack of homogeneity
of human fecal samples as well as observing significant day to day BA fluctuations [7].
Therefore, for best practice it is recommended that multiple samples be collected over a specific
timeframe, pooled together and thoroughly homogenised before extraction [2,7]. As feces is a
complex matrix some effort has been spent developing methods for sample preparation. These
have been comprehensively reviewed and reported elsewhere [5]. In brief, some studies involve
preparation of wet fecal samples [9], but a more popular choice appears to be lyophilisation
and re-constitution [8,10,11]. Most sample preparation methods involve a solvent extraction
step, followed by solid phase extraction to further purify samples and eliminate contamination
of the column and the mass spectrometer [5]. More recently, Franco et al (2019) extracted oxobile acids in wet fecal samples with isopropanol and omitted any sample clean-up step, and did
not report any detriment to results or instrumentation.
For large studies the stability of the BA post extraction is also of interest, but interestingly does
not feature in the literature. The complexity and variability of the sample matrix, the large
concentration range reported for BA and the lack of a standardised protocol make comparisons
between studies very difficult. Our aim was to develop a robust, simple method suitable for
studies involving large cohorts. A secondary aim was to understand the stability of the extracts
and standards post extraction and prior to analysis.
2. Materials and methods
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2.1. Chemicals
LC-MS grade water, methanol and acetonitrile were purchased from Thermo Fisher Scientific
(Sydney, Australia). Chenodeoxycholic acid (2,2,4,4-d4) (CDCA-d4), cholic acid (CA),
chenodeoxycholic acid (CDCA), deoxycholic acid (DCA), lithocholic acid (LCA),
ursodeoxycholic acid (UDCA), glycodeoxycholic acid (GDCA), glycocholic acid (GCA), glycolithocholic acid (GLCA), taurochenodeoxycholic acid (TCDCA), taurocholic acid (TCA),
taurodeoxycholic acid (TDCA), tauroursodeoxycholic acid (TUDCA) were purchased from
Toronto Research Chemicals (Toronto, Canada). Lithocholic acid (2,2,4,4-d4) (LCA-d4) and
taurodeoxycholic acid (2,2,4,4-d4) (TDCA-d4) were obtained from Cambridge Isotope
Laboratories, Inc. (Massachusetts, USA). Deoxycholic acid (2,2,4,4-d4) (DCA-d4) was
purchased from Sigma- Aldrich (NSW, Australia).
2.2. Preparation of standards
Individual stock solutions (2.5 mM) of 12 target bile acids (DCA, CDCA, UDCA, CA, GCA,
GLCA, GDCA, LCA, TUDCA, TCDCA, TDCA, and TCA) and 4 labelled internal standards
(DCA-d4, LC-d4, CDCA-d4 and TDCA-d4) were prepared in methanol and stored until use at
-80 °C. Mixed calibration standard solutions (nine) containing all 12 target BA at the
concentration range of 97.66 – 25,000 nM for UDCA, CA, GCA, GLCA, GDCA, TUDCA,
TCDCA, and TDCA; 585.94 – 300,000 nM for LCA and DCA; and 195.31 – 100,000 nM for
CDCA and labelled internal standards (5000 nM of TDCA-d4 and CDCA-d4, and 10000 nM
of LCA-d4 and DCA-d4) were prepared in 0.1 % aqueous formic acid.
Standards for precision and accuracy (PAS) experiments were prepared in water containing 0.1
% formic acid at 4 different concentrations to cover a large concentration range (low to high);
PAS1 to PAS4 for CA, GCA, TCA, TCDCA, TDCA, TUDCA and UDCA were 195.31,
390.63, 1562.5, and 6250 nM; for GDCA and GLCA were 390.63, 1562.5, 6250 and 25000
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nM; for CDCA were 781.25, 1562.50, 6250, and 25000 nM; and for LCA and DCA were
585.94, 2343.75, 4687.50, and 18750 nM, respectively.
Mixed standards solutions at low (LS), medium (MS) and high (HS) concentration were
prepared for the recovery and accuracy experiments. The LS, MS and HS for CDCA, CA,
GCA, GDCA, GLCA, TCA, TCDCA, TDCA, TUDCA and UDCA were 200, 2000, and 20000
nM, and for LCA and DCA were 1000, 10000, and 100000 nM, respectively, and were prepared
in water containing 0.1 % formic acid.
For the stability study, the following standards were prepared in 0.1 % aqueous formic acid:
SS1 to SS5 were 195.31, 781.25, 3125, 12500, and 50000 nM for CA, GCA, GDCA, GLCA,
TCA, TCDCA, TDCA, TUDCA and UDCA, 781.25, 3125, 12500, and 50000 nM for CDCA,
and 2343.75, 9375, 37500, 150000, and 600000 nM for LCA and DCA, respectively.
2.3. Instrumentation conditions
Chromatographic separation was performed on an Ulti-Mate 3000 Liquid Chromatograph
(Thermo Scientific, CA, USA) coupled to a Thermo Scientific TSQ Quantiva Triple
Quadrupole Mass Spectrometer equipped with an ESI source. The optimal separation was
achieved on ACE C18 (100 mm × 2.1 mm ID; Advanced Chromatography Technologies,
Scotland) with 1.7 µm particles and a mobile phase of water containing 0.1% formic acid (A)
and acetonitrile (B). The gradient separation was completed in 14 min with the initial
conditions of 99.9 % solvent A and 0.1 % solvent B. The initial conditions were held for 1 min,
then solvent B was increased to 65 % over 3 min followed by a further rise to 99.9 % over 9
min. Mobile phase B was returned to its initial conditions over 0.5 min before the column was
re-equilibrated for 1.5 min. The flow rate was 0.2 mL min-1 and the column temperature was
maintained at 40 °C with an injection volume of 2 µL.
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The detection was performed in negative mode (2500 V) and the spectra were acquired in
multiple reaction monitoring (MRM) mode. The cycle time was set at 0.5 s and the dwell time
ranged from 20.8 to 26 ms for all analytes. Argon gas was selected as collision gas and nitrogen
as nebulizer and heater gas. The MS conditions were gases (arbitrary units) sheath 35, auxiliary
15, sweep 0; ion transfer temperature 325 °C and vaporizer temperature 275 °C. For
optimisation of MS parameters, individual standard solutions were prepared in methanol (5
µM) and introduced into (-)-ESI source by direct infusion at a flow rate of 20 µL min-1. A
summary of optimal MS parameters for each standard and internal standard including precursor
ion, product ions transitions for BA with stable adequate fragment ions, selected ion recording
for BA with unstable fragment ions, and collision energies are presented in Table S-1.
2.4. Fecal sample preparation
Fecal samples were collected from all bowel motions over a 24 h period. If more than one stool
sample was collected, they were homogenised as individual samples and then pooled and
homogenised again. Aliquots were transferred into 2 mL screw top storage tubes and stored at
-80 °C until analysis.
Each accurately weighed (approximately 0.5 g) wet fecal aliquot was thawed and extracted
with 1.00 mL ice-cold methanol containing internal standards (5,000 nM of TDCA-d4 and
CDCA-d4, and 10,000 nM of LCA-d4 and DCA-d4). The sample was shaken for 30 min at 4
°C and centrifuged at 21,000 rpm for 20 min. The supernatant (100 µL) was transferred to a
separate 1.5 mL low-bind microcentrifuge tube with boil-proof cap to ensure maximum sample
recovery and diluted v/v (1:5) with 0.1 % aqueous formic acid solution. The extract was then
filtered through 0.22 µm polypropylene syringe filter and transferred to 2 mL amber glass short
thread LC vial with 0.1 mL clear glass micro insert for analysis.
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To obtain the dried weight of each fecal sample analysed, a duplicate 0.5 g of each wet fecal
sample was dry-lyophilised using a freeze dryer (Sublimate 2, Esco E.U.) and the content of
water in each sample was calculated by comparing the weight of the feces sample before and
after drying. The normalised dried weight (in g) was used for calculation of the final BA
concentration in fecal samples.
The BA concentration in wet feces was expressed as nmoles L-1 of extract, which was then
converted to nmoles g-1 of dry feces by applying the following formula:

= 0 ×

(1)

Where C is expressed as concentration in nmoles g-1 of feces, C0 is the measured concentration
as nmoles L-1 of ex-tract, V is the volume of extraction solvent in L, and m is the weight of
dried feces in g.
2.5. Optimization of stationary phase
Several columns including a Thermo Scientific Accucore™ 150 Amide HILIC (100 × 2.1 mm;
2.6 µm) column, a Thermo Scientific Syncronis™ HILIC (100 × 2.1 mm; 1.7 µm) column, an
ACE C18 PFP (100 × 2.1 mm; 1.7 µm) column, an ACE C18 AR (100 × 2.1 mm; 1.7 µm)
column, a Thermo Scientific Hypersil GOLD™ aQ (100 × 2.1 mm; 1.9 µm) column and an
ACE C18 (100 × 2.1 mm; 1.7 µm) column were tested to obtain the best separation of the
targeted bile acids. All reversed phase stationary phases were tested with water and ACN
containing 0.1% formic acid as the mobile phase. HILIC stationary phases were tested with
ACN: water containing 15 mM ammonium acetate adjusted to pH 5 with acetic acid as a mobile
phase.
2.6. Optimization of extraction temperature
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To determine the optimum extraction temperature a comparison be-tween cold and warm
extraction was conducted. Wet fecal samples were extracted in duplicate with ice-cold (4 °C)
methanol and with 37 °C methanol containing internal standards as described in section 2.4.
Percentage agreement of the target bile acids from cold extraction versus warm extraction were
calculated using equation (2), where Ccold is the concentration of the given analyte in the cold
extraction and Cwarm is the concentration for the warm extraction.

× 100%

=

(2)

The mean percentage agreement was calculated for each bile acid extracted at two different
temperatures.
2.7. Extraction recovery
The extraction recovery or apparent recovery was estimated by spiking 10 µL of LS, MS, HS
BA standards (section 2.2) into 3 different fecal samples (0.5 g). The spiked fecal samples were
then extracted using 1 mL ice-cold methanol containing internal standards as described in
section 2.4. The baseline (unspiked) and spiked feces samples were analysed and percentage
absolute recovery was calculated according to equation (3), where Cbaseline is the calculated
unspiked analyte concentration, Crecovered is the calculated spiked analyte concentration, and
Cspiked is the absolute concentration of spiked standard added to the sample.
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This experiment was repeated in triplicate.
2.8. Clean-up
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× 100%

(3)

The optimal pre-analysis clean-up method was investigated: liquid-liquid extraction and a
method using a 3kDa molecular weight spin cut-off filter (Amicon Ultra, 0.5 mL SigmaAldrich, Cork, Ireland) were tested on methanol extracts from five wet fecal samples.
For liquid-liquid extraction, the BA were isolated from 500 µL of fecal methanol extract
(diluted 5 times with water) with 500 µL n-hexane (3 times). The n-hexane layers were
collected and dried under a nitrogen stream. The hexane residue was reconstituted with 250 µL
0.1% aqueous for-mic acid and transferred to the LC vial for analysis. For clean-up using the
3 kDa cut-off filter, 300 µL of diluted (1in 5) fecal extracts were filtered and centrifuged for
20 min at 4 °C and 21000 rpm. The filtrates were then transferred to the LC vials for analysis.
2.9. Comparison of extraction of wet and dry fecal samples
To compare dried feces versus wet feces extraction methods, wet, dried and spike-dried fecal
samples were prepared. A pooled fecal sample was prepared by combining 5g aliquots from 6
individual wet samples. After thorough homogenisation 12 aliquots (0.5 g each) were treated
as follows; 4 aliquots (D) were dry-lyophilised using a freeze dryer; a further 4 aliquots (SD)
were spiked with four internal standards and then dry-lyophilised; and another 4 aliquots (W)
were frozen at -80 °C until further analysis. The eight dried fecal extracts were rehydrated to
contain water levels consistent with the wet fecal sample.
The four (SD) that were spiked prior to drying were extracted with ice cold methanol while the
four (D) un-spiked dried fecal samples were extracted with ice cold methanol containing the
internal standards. The four frozen wet fecal samples (W) were thawed and extracted with 1
mL ice-cold methanol containing internal standards. All 12 samples were analysed and the
mean percentage agreement for the BA recorded for each extraction method were calculated
by applying equation (4), where Cdried is the analyte concentration after rehydrating the dried
spiked or dried un-spiked sample, and Cwet is the analyte concentration in the wet sample.
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2.10. Method validation
The method was validated in accordance with ICH and IUPAC guidelines [12,13].
2.10.1. Linearity, limit of detection and limit of quantification
The linearity of the method was evaluated by injecting the nine calibration standards (see
section 2.2) and plotting the peak area ratio of each analyte to the internal standard (y-axis)
versus the concentration (x-axis). Limit of detection (LOD) and the limit of quantification
(LOQ) of the method were expressed as concentration with S/N equal to 3 and 10, respectively.
2.10.2. Precision, trueness, and accuracy
Method precision and trueness were evaluated by intra-day and inter-day analyses of a set of
BA standards (PAS). For intra-day and inter-day analysis, the PASs were injected six times per
day and for 6 consecutive days, respectively. The resulting concentrations of the replicate
analysis were used to calculate the coefficient of variance (% CV) and thus precision. Subsequently, the mean concentration relative to the nominal concentration was used to calculate %
bias and hence the trueness of the method.
Accuracy was evaluated by spiking 10 µL of LS, MS and HS BA standard solutions (see section
2.2) into 3 separate aliquots of pooled fecal extract (as described in section 2.9). The baseline
(un-spiked) and spiked extracts were analysed, and percentage apparent recovery was
calculated according to equation (4).
2.10.3. Matrix effect
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To evaluate potential matrix effects, and in the absence of a stripped fecal extract (fecal matrix
without the BA), the following approach was adopted: a pooled fecal sample was extracted as
per the protocol (section 2.4) and the concentration of BA determined. A solution of BA of
similar concentration to this fecal sample was then prepared in water with 0.1 % formic acid
(no attempt to matrix match). The fecal extract and BA solution were then both spiked with 10
µL of HS (see section 2.2) and the detector response compared for both and the percentage
matrix effect (matrix ion suppression/enhancement) was calculated using equation (5), where
Rmatrix is the response of the given analyte in matrix and Rstandard is the response in standard
solution.

12 =

. )3

−

(. *

× 100%.

(5)

(. *

If ME ∼ 0% there is no observed matrix effect, and if ME > 0% then an ion-enhancement
occurred, and if ME < 0% an ion-suppression occurred.
2.10.4. Short-term storage stability
To investigate the effects of pre-analytical storage on subsequent BA recovery, BA standards
(SS1 to SS5) and 4 fecal sample extracts (Ext 1 to Ext 4) were prepared using the optimized
method and stored in 2 mL amber glass short thread LC vial with 0.1 mL clear glass micro
insert under 2 different storage conditions: at 6 °C in the autosampler and at room temperature
(22-25 °C) for 12 and 24 hours. The baseline (t=0) and t=12 h and t=24 h extracts were
analysed, and percentage relative recovery was calculated according to equation (6), where C0
is the measured analyte concentration at baseline (t = 0) and Ct is the concentration at t = 12 or
24h.

"! #. =

.

× 100%

6

12

(6)

Two-way repeated measure analysis of variance (RM-ANOVA) was performed to investigate
the interaction of time and sample type (SS vs Ext) and to determine whether storage conditions
have a detrimental effect of recovery efficiency.
2.10.5. Long-term storage stability
To investigate the effects of multiple freeze thaw cycles on subsequent BA recovery, standards
(SS1 to SS5) and fecal sample extracts (Ext 1 to Ext 4) were again prepared using the optimized
method, stored in 2 mL amber glass short thread LC vial with 0.1 mL clear glass micro insert
and then exposed to up to three -80 °C freeze-thaw cycles. The baseline (fresh samples) and 3
freeze/thaw extracts were analysed, and percentage relative recovery was calculated according
to equation (6), where C0 is the measured analyte concentration at baseline and Ct is the
concentration at t = 1,2 and 3 freeze/thaw cycles. Two-way RM-ANOVA was performed to
investigate the interaction of number of freeze/thaw cycles and sample type (SS vs Ext) and to
determine whether freeze/thaw cycles have a detrimental effect of recovery efficiency.
2.11. Application
The BA extraction and detection method was employed for quantification of target BA in 100
fecal samples from healthy adult individuals. The measured concentration (nM) was
normalised to dried fecal weight (g), thus converted to nmol g-1.
3. Results and Discussion
3.1. Analytical separation method development
Two HILIC and four reversed phase separation columns were trialled for the separation of the
target BA. As the analytes were poorly retained on the HILIC columns tested (Thermo
Scientific Accucore™ 150 Amide HILIC and Thermo Scientific Syncronis™ HILIC) and there
were several instances of coelution, these columns were not explored further (data not
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provided). The four reversed phase columns including two C18 columns (ACE C18, Thermo
Scientific Hypersil GOLD™ aQ) and two C18 columns with embedded functionalities,
specifically aromatic functionality (ACE C18 AR) and pentafluorophenyl rings (ACE
C18_PFP) were investigated for separation of the targeted BA and, in particular, the pairs
CDCA/DCA and TCDCA/TDCA which form negative molecular ions of the same mass/charge
ratio 391 and 498 respectively. A simple mobile phase gradient consisting of acetonitrile and
water with 0.1 % formic acid was used for the separations. Yin et al (2017) recommended the
use of a weakly acidic mobile phase (pH 3-4) and the absence of ammonium based buffers to
maximise separation and formation of negative ions respectively [6]. Also, acidic mobile
phases (pH ~ 4) of aqueous acetonitrile and/or methanol with formic acid, where taurine
conjugates are deprotonated and glycine and unconjugated bile acids exist predominantly in
their unionised form, were recommended by Griffiths and Sjövall (2010) [2]. While close to
baseline separation was observed for one of two pairs (CDCA/DCA or TCDCA/TDCA) using
the ACE C18 PFP or ACE C18 AR columns, baseline resolution of both BA pairs was achieved
using the ACE C18 column. Resolution was calculated as 1.20 and 1.04 for CDCA/DCA and
TCDCA/TDCA respectively with excellent symmetrical peaks (Table S-2). Furthermore, the
excel-lent peak shape, and resolution of these pairs was maintained after 800 injections (Fig. 1
and Table S-2).
3.2. Comparison of fecal sample preparation and bile acids extraction methods
A range of methods have been reported for extraction of BA from feces, several of which are
not particularly amenable to large scale studies such as refluxing feces sample in alkaline
ethanol solution at elevated temperature (80 °C) for 1 h, ultra-sonication for 1h or alkaline
hydrolysis using 1 N NaOH followed by long incubation (2.5 h) [8,11]. Franco et al. reported
a simple extraction involving wet feces and isopropanol (optimal for oxo-bile acids) at 37 °C
[9]. A modified approach was adopted here where wet feces was extracted in methanol, and
14

the need to use heat to aid extraction as described by Franco et al. was investigated: six fecal
samples were extracted at two temperatures (4 °C and 37 °C). The mean recovery of the BA
from the cold extraction when compared to the warm extraction ranged from 96.40 to 103.62
% with CV 1.32-5.25 % (Table S-3) indicating that the extraction was not influenced by the
temperature. Also, an inspection of the chromatograms generated in full scan MS mode for the
4 °C and 37 °C extracts determined that the cold extraction provided a cleaner spectrum.
The extraction efficiency of the method was then tested. Aliquots of three different fecal
samples were spiked with varying concentrations of the BA (zero, low, medium and high
concentrations of BA) and then extracted as per the protocol. The apparent recovery of the
investigated BA was acceptable and in the range 83.58 to 122.41 % (Table S-4) [12,13].
Two clean-up methods, liquid-liquid extraction with n-hexane and extraction with a 3 kDa cutoff filter were trialled and compared with no clean-up of the extracts other than filtration
through a 0.22 µm filter. For all the BA there was loss of analyte when a clean-up method was
applied, and the loss of analyte was usually greater when the 3kDa filter applied (Fig. S-1). For
example, the signal for LCA, one of the key BA in human feces, reduced by more than 300
times after liquid-liquid extraction and was not detected at all after use of the 3kDa filter
compared to no clean-up extracts. The glycine conjugated BA are typically present in relatively
low concentrations, and both clean-up methods resulted in a reduction in signal for GDCA and
GCA and total loss of signal for GLCA. Similarly, the use of a clean-up method compromised
the detection of TDCA and TCA which are typically present in low concentrations in human
feces. Therefore, a clean-up method was not adopted, and the possible impact of no clean-up
on the column and the MS signal over time was monitored. The loss of resolution of the BA,
increase in column pressure and loss of MS signal consequences that can be associated with no
sample clean-up was not evident in over 800 injections.
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Our goal was to develop a robust, high throughput method for extraction and quantification of
BA in human feces that maintained sample integrity, hence our approach to extract from wet
feces. The variable water content in feces is well documented, and to be able to report BA
concentrations that are independent of water content, a second aliquot of fecal material was
dried to determine and correct for water content. The duplicate preparations also allowed
presentation of BA data as wet or dried weight, allowing for greater comparisons with the
literature. The BA concentrations for 100 wet fecal samples when converted to dry weight
(Table 1), were consistently higher than those re-ported in the literature for dried feces
[8,10,11,14]. It is well recognised and reported that BA concentrations vary dramatically
between individuals and even for a given individual [7]. Furthermore, meaningful comparisons
between studies is often difficult with differences in extraction, type of sample (healthy vs
diseased etc), population size, reporting format (mean versus median) and unit of BA
concentration reported (nmol g-1; ug mL-1 dried or wet). However, the differing concentrations
for wet and dried feces did prompt an investigation into the impact of drying the fecal sample
prior to extraction on BA recovery. An initial experiment involved lyophilising aliquots of
pooled fecal material, re-hydrating with water and then extracting with methanol as per the wet
fecal protocol. Aliquots of the same pooled, but wet fecal material, were extracted as per the
protocol for comparison purposes. The concentrations of BA were significantly lower in the
dried extracts when compared to the wet fecal extracts (data not shown) and this was true for
all of the BA, so much so that the experiment was repeated, but with an extra variable. In the
follow up experiment a further four aliquots of pooled wet feces were spiked with internal
standards prior to drying. The recovery of the two main BA in human feces, LCA and DCA,
in the dried ex-traction was 60 and 70 % less (respectively) of that detect-ed in the wet fecal
extraction. The recovery for CDCA and CA from dried feces was 50% that recovered from wet
feces. The recovery of the more minor BA, the taurine and glycine conjugated bile acids were
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even less: the glycine conjugated BA recoveries were between 0.2 and 23 % (Fig. 2). To
confirm that the low concentration recorded for the dried extracts was not a detection issue, the
LOQ for the BA in fecal samples was determined. The LOQ for the taurine conjugated BA
were at least 10 times lower than the concentrations reported for the dried fecal samples (see
Table 2 for LOD and LOQ data). The taurine conjugated BA recoveries from the dried fecal
extracts were just 2% or less, and a check of LOQ data confirmed that it was not due to a
detection issue. The aim of this work was not about developing an extraction method for dried
fecal material, so no attempt was made to optimise the extraction. Undoubtedly, a longer
extraction time, and/or sonication or heat might improve extraction efficiency. However, these
results do highlight the potential for reduced and inconsistent bile acid recovery from dried
fecal samples. Fortunately, the inclusion of internal standards in the feces prior to drying was
able to largely correct for the poor extraction efficiency of BA. Percentage agreement between
dried fecal extraction after correction using the internal standards was between 78 -115 % of
the wet fecal extracts for all BA (Table 5-S). These findings highlight how sample preparation
can significantly impact extraction efficiency and may explain some of the variation in
concentrations reported for the BA in the literature.
3.3. Linearity, limit of detection and limit of quantification
A 10-point calibration curve for each analyte was constructed by plotting analyte response
(peak area of the analyte to the peak area of corresponding internal standard) versus
concentration in nM. Linearity (R2 > 0.995) was observed for all analytes in the concentration
range 97.66-25,000 nM for UDCA, CA, GCA, GLCA, GDCA, TUDCA, TCDCA, and TDCA;
585.94-300,000 nM for LCA and DCA; and 195.31-100,000 nM for CDCA. Linear regression
was used to interpolate the concentration of analytes in fecal extracts.
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The limit of detection (LOD) is the lowest level of detectable analyte concentration that can be
reliably distinguished from the background by an analytical system (S/N = 3). Whereas limit
of quantification (LOQ) is the lowest quantifiable level of analytes that can be measured with
an acceptable level of confidence (S/N = 10). The LODs and LOQs for all analytes were in the
range 2.5-7.5 nM and 10 - 15 nM, respectively (Table 2), The LOQs recorded for the bile acids
here are consistent with those reported by Humbert et al (2012) which ranged from 14.6-18.6
nM [10]. More useful is to relate the LOQ of the method to the concentration of BA in fecal
extracts, which interestingly has rarely been reported. This measure of LOQ was an order to
several orders of magnitude below the median bile acid concentrations reported for a study
involving over 100 fecal samples (Tables 1 and 2).
3.4. Precision, trueness, and accuracy
Precision (%CV) and trueness (%bias) of the method were determined by intra-day and interday analyses of four PAS’s (different concentration of calibration standards; PAS1, PAS2,
PAS3 and PAS4). For intra-day analysis, six replicates of PAS’s were injected in one day,
whereas for inter-day, one replicate of each PAS were injected for six consecutive days. For
both intra-day and inter-day analyses, the CV ranged from 0.62 to 19.41 % and bias ranged
from -20.68 to 20.23 %, which complies with the acceptable limit (Table 6-S) [12,13]. These
results indicated that the method is precise and accurate. Additionally, recoveries across three
concentration ranges from pooled fecal extracts were calculated to evaluate the analytical
method accuracy. The % apparent recovery ranged from 86.32 to 116.95 % which confirms
the accuracy of the developed method (Table 7-S). These results were in agreement with the
acceptance criteria for method recovery (100 ± 20 %) and also demonstrate an excellent
alignment between expected and true values with the confidence intervals in the complex fecal
matrix [12,13].

18

3.5. Matrix effect
In quantitative LC–MS analysis matrix effects are major concerns due to their dramatic effect
on accuracy, precision and sensitivity of measurement especially when the concentration of
target analyte is low such as the taurine conjugated BA in this study. Although, matrix effect
cannot be completely avoided during LC-MS analysis, a number of strategies can be employed
to correct for matrix effects [15]. In this study, labelled internal standards were used to correct
for signal enhancement or suppression due to matrix effects and to correct for loss of analyte
during sample preparation. Since isotopically labelled standards were not available for all
studied BA, four isotopically labelled standards (TDCA-d4, CDCA-d4, LCA-d4 and DCA-d4)
were used that reflected the different classes of BA. To evaluate potential matrix effects and to
see if the applied internal standards were able to account for matrix effect in sample extracts,
parallelism was assessed. Parallelism was evaluated by comparing the analyte response in postextract spiked matrix to that of a standard solution at the same concentration as the spike. Ion
suppression/enhancement was calculated to be less than ± 5% for all target BA ranged -3.40 to
3.66% (Table 7-S).
These results revealed that the matrix effects were not significant and thus the applied internal
standards were able to compensate for any loss or enhancement and therefore, matrix effects.
3.6. Stability
The stability of the BA standards and the BA in the fecal extracts was investigated. Five
standards (SS1 to SS5) and four fecal extracts (Ext1 to Ext 4) were stored under three different
conditions: at 6 °C in the LC auto sampler for 24 h; on the lab bench (23-25 °C; room temperature) for 24 h, and stored at -80 °C freeze but with up to three freeze-thaw cycles.
After storage in the autosampler at 6 °C for 24 h the mean percentage recoveries for the target
BA in both the standards and the extracts ranged from 90.58-107.89 %, which is within ± 20
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% and therefore acceptable [12,13] (Table 8-S). Furthermore, there was no statistically
significant change in the mean percentage recoveries reported after 12 or 24 h storage at 6 °C
(Fig. 3A). In contrast, the storage of the sample extracts and BA standards at room temperature
significantly impacted the recovery of some BA. Specifically, the recoveries of CA, UDCA,
TCA and GLCA in both the standards and the extracts were significantly and negatively
impacted (pcondition = 4.37×10-6, 0.0004, 0.006, 1.44×10-7, respectively) by storage at room
temperature after just 24 h compared to 12 h (see Table 10-S). For example, the mean
percentage recovery of CA after 12 h, irrespective of storage conditions and sample type, was
around the ~100% mark. However, after 24 h both the extracts and standards stored at room
temperature were less than 70 % recovery (see Fig. 3A). For GLCA the mean percentage
recovery was ~100% for all samples stored at 6 °C at both the 12 h and 24 h time points. However, all samples stored at room temperature had reduced recovery to < 70%. For the bile acids
CDCA, DCA, GCA, LCA, TCDCA and TDCA the mean % recovery after 24 h storage at room
temperature ranged from 91 to 100 % and from 89 to 106 % for the standards and extracts
respectively and was not statistically different to the recoveries reported for no storage, or
storage at 6 °C. Interestingly, the results were different again for TUDCA and GDCA, where
their mean percentage recoveries were significantly lower in the standards, but not in the
extracts (p= 0.0006 and 0.040, respectively). Comparative plots of all BA are provided in Fig.
S-2. Recovery summary data for all BA are provided in Table 8-S. The instability of some BA
in the sample extracts stored at room temperature may be due to the presence of bacteria in
feces, which can modify the BA composition [7]. However, the use of MeOH as the extraction
solvent should minimise bacterial growth in the sample extract. Storage of the sample extracts
at low temperature is recommended to avoid possible bacterial degradation of BA structures.
The stability of the BA in standard solutions and in fecal extracts stored at -80 °C and subject
to freeze-thaw cycles was also investigated. The percentage recovery of the BA in the extracts
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and the standards varied with the specific BA and the number of freeze thaw cycles. After just
one freeze-thaw cycle, all the BA, with the exception of GLCA in the extract, in both the
extracts and the standard solutions, had mean recoveries of greater than 90 %. After three
freeze-thaw cycles, CA, DCA, TCDCA and TUDCA maintained mean percentage recoveries
of greater than 90%, while the recoveries for GCA, CDCA, TCA, TDCA, UDCA and GDCA
were somewhat compromised with the extra freeze thaw cycles and reported mean percentage
recoveries of between 74-105 %, and in some instances this lower recovery was statistically
significant when compared to the recovery after just one freeze-thaw cycle (p= 0.60, 0.003,
0.42, 0.08, 0.44, and 0.23, respectively; see Table 10-S). Both CDCA and GLCA had
recoveries of less than 80 % for the extracts after three freeze thaw cycles. Comparative plots
of all BA are provided in Fig. S-3. Recovery summary data for all BA are provided in Table 9S.
While it is not clear why some analytes are more susceptible to varying storage conditions, this
study does highlight the need for fecal extracts and standards to be queued in a refrigerated
autosampler for LC-MS analysis to maintain analyte integrity. When longer term storage of
standards and extracts is required prior to analysis, it is important to minimise freeze-thaw
cycles. For standard solutions, sub-aliquoting is recommended to avoid multiple freeze thaws.

3.7. Application to fecal samples
The extraction of BA from wet feces and analysis on an ACE C18 column was successfully
applied for quantification of the 12 BA in 100 fecal samples obtained from healthy individuals.
A second aliquot of fecal material for each sample was dried and weighed to normalise for
water content. The concentration range recorded for each BA is reported in Table 1. The
literature reports for BA in fecal material tend to focus on just the four key BA (CA, CDCA,
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DCA and LCA) and data is presented either as dry weight or wet weight, but not both, making
comparisons difficult [8–11]. Therefore, here we have presented mean, median, % BA
concentrations for all the BA and total primary and secondary BA concentrations (Table 1).
We have included available data from the literature for comparison purposes [8,10,11,14]. In
agreement with other studies, DCA and LCA are the two key BA present in feces and they
contribute 80% or more of the total BA content. A comparison of our BA data (generated by
extracting from wet feces but expressed as dry weight) with the available dry weight literature,
highlights the higher concentrations (mean and median) reported for our study for DCA and
LCA. This may be due purely to the cohort, given the large natural variation in BA
concentrations, but it may also be due in part to the poor extraction recovery of BA from dried
feces, as our study has highlighted. Importantly, the higher concentrations reported for our wet
fecal extraction method, also ensured that the minor BA were efficiently extracted and
quantifiable (Table 1).
4. Conclusions
We report here a robust, sensitive method for the quantitative determination of 12 BA from
feces using LC-MS. The minimal sample preparation, extraction into methanol, makes the
method applicable to studies with large cohorts. The extraction from wet feces maximises
sample integrity and avoids issues of poor recovery experienced with dried fecal material. If
the use of dried fecal material is necessary, then extraction efficiency and repeatability need to
be tested, and spiking of the fecal material before drying is essential to capture any loss in
recovery. The extracts must be stored cold (6 °C) prior to analysis and if analysis is not possible
after extraction, the extracts need to be stored at -80 °C and multiple freeze-thaws are to be
avoided.
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Table 1. Comparison of fecal bile acid concentrations in this study with other studies

Method

Ours

Humbert et al (2012)9

Kakiyama et al (2014)11

Perwaiz et al (2002)10

Mouzaki et al (2016)13

(n = 100)

(n = 19)

(n = 10)

(n = 5)

(n = 25)

LC-MS

LC-MS

LC-MS

GC-MS

-1

-1

Unit

nmol/g dried feces

nmol g dried feces

umol g dried feces

BA*

12

26

9

Concentrati
on range

Mean
SD

±

CA

BLOQ** 2118.48

214.3
553

±

CDCA

10.98
4495.22

431.6
1065

±

DCA

202.37
32506.10

10536.
8491

±

LCA

353.27
16656.03

6914.5
4498.7

±

UDCA

BLOQ** 1933.92

187.10
505

±

GDCA

5.42
167.65

-

43.26
43

±

GCA

BLOQ
98.13

-

1968.8
5879

±

GLCA

BLOQ
51.88

-

17.96
29

±

TCDCA

BLOQ
25.00

-

5.16
6.6

±

TCA

BLOQ
75.18

-

4.48
16

±

TDCA

BLOQ
49.96

-

9.38
13

±

TUDCA

BLOQ
486.30

-

8.11 ±

PBA***

-

2624.2
6055

SBA****

-

Total BA

-

*Number

-

LC-MS-MS
-1

nmoles g-1 dries feces

ug 100mg dried feces
4
Method 1

Total
(%)

Median

Total (%)

<1

28

1.3

45

2.1

37.0

1101

51.5

199.4
± 3.0

46.0

952

44.5

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.05

-

-

-

-

-

-

-

-

-

-

0.00

0.04

-

-

-

-

-

-

-

-

-

-

208.4

12.9

137.7

4.3

-

-

-

-

-

-

65

3.0

17716.9 ±
12683

16548.6

87.1

2950.9

93.1

-

-

-

-

-

-

2063

96.5

20341.1 ±
15984.6

17097.5

-

3170.5

-

-

-

-

-

-

-

2138

-

81
±

Median

Tota
l (%)

Mean ±
SD

Total (%)

Median

Total (%)

Mean
± SD

20.8

1.1

44.7
48

±

1.4

0.01

22.0

3.5
3.9

81.4

2.1

54.8
72

±

1.7

0.0

0.0

8482.7

51.8

1920.1 ±
1391

60.6

1.9

6251.4

34.0

1016.6 ±
647

32.1

43.76

0.92

-

30.04

0.21

6.47
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Method 2
Total
(%)

Mean
± SD

2.0

3.7
2.5

-

-

-

41.8

97.5 ±
2.2

41.0

158.5
± 4.2

1.5

33.1

155.5
± 4.4

66.0

-

-

-

-

-

-

-

-

9.68

-

-

-

11.55

0.09

-

-

2.91

0.03

-

0.61

0.02

5.46

of detected bile acids, **BLOQ: Below Limit of Quantification, ***Primary bile acids, ****Secondary bile acids

26

±

±

Table 2. LOD and LOQ of the method
Compound

LOD
(nM)*

CDCA

5

15

0.23

0.76

CA

5

15

0.34

1.15

DCA

2.5

10

0.14

0.46

GCA

5

15

0.14

0.48

GDCA

5

15

0.18

0.59

LOQ
(nM)*

LOD
(nmole g-1)**

LOQ
(nmoles g-1)**

GLCA

5

15

0.25

0.82

LCA

2.5

10

0.45

1.51

TCA

7.5

12.5

0.07

0.23

TCDCA

5

15

0.16

0.53

TDCA

5

15

0.28

0.93

TUDCA

5

15

0.08

0.25

UDCA

7.5

12.5

0.47

1.56

*Calculated
**nmoles/g

from the standard solutions

dry weight, calculated from fecal samples (n = 5)
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Figure 1
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Figure 2
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Figure 3
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Figure Captions
Fig. 1. Total ion chromatograms of bile acid in fecal extract
Fig. 2. Recoveries of wet, dried and spike-dried extractions
Fig. 3. Stability of cholic acid (CA) in standard solutions and fecal extracts at 6°C and at room
temperature over 24 h (A); and stability of chenodeoxycholic acid (CDCA) in standard
solutions and fecal ex-tracts after three freeze-thaw cycles (B)
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